Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 11 | 2024 | 628 | 1.960 |
Why?
|
| Critical Illness | 11 | 2024 | 598 | 1.750 |
Why?
|
| Platelet Transfusion | 5 | 2020 | 53 | 1.250 |
Why?
|
| Anticoagulants | 8 | 2024 | 583 | 1.100 |
Why?
|
| Thrombosis | 4 | 2024 | 519 | 1.070 |
Why?
|
| Postoperative Care | 2 | 2019 | 296 | 0.870 |
Why?
|
| Delphi Technique | 4 | 2024 | 210 | 0.840 |
Why?
|
| Thrombophilia | 1 | 2021 | 42 | 0.750 |
Why?
|
| Hemorrhage | 5 | 2024 | 460 | 0.720 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 101 | 0.710 |
Why?
|
| Blood Preservation | 2 | 2019 | 29 | 0.710 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 124 | 0.620 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2019 | 50 | 0.600 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 141 | 0.600 |
Why?
|
| Aspirin | 1 | 2019 | 221 | 0.560 |
Why?
|
| Drug Monitoring | 2 | 2024 | 166 | 0.470 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 5 | 0.460 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2014 | 35 | 0.450 |
Why?
|
| Intensive Care Units, Pediatric | 5 | 2023 | 477 | 0.430 |
Why?
|
| Sepsis | 3 | 2024 | 478 | 0.430 |
Why?
|
| Abdomen, Acute | 1 | 2013 | 14 | 0.420 |
Why?
|
| Child | 21 | 2024 | 24486 | 0.410 |
Why?
|
| Critical Care | 1 | 2018 | 650 | 0.410 |
Why?
|
| Status Epilepticus | 1 | 2014 | 144 | 0.400 |
Why?
|
| Infant | 15 | 2024 | 12464 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 723 | 0.400 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2012 | 6 | 0.400 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 192 | 0.390 |
Why?
|
| Cough | 1 | 2013 | 88 | 0.390 |
Why?
|
| Hypercalcemia | 1 | 2012 | 39 | 0.390 |
Why?
|
| Vomiting | 1 | 2013 | 115 | 0.390 |
Why?
|
| Hyperammonemia | 1 | 2012 | 62 | 0.380 |
Why?
|
| Infant, Newborn | 12 | 2024 | 8181 | 0.380 |
Why?
|
| Child, Preschool | 15 | 2024 | 14055 | 0.380 |
Why?
|
| Water-Electrolyte Balance | 1 | 2011 | 80 | 0.370 |
Why?
|
| Precision Medicine | 1 | 2014 | 313 | 0.370 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 134 | 0.360 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 121 | 0.350 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 625 | 0.350 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 1813 | 0.350 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2894 | 0.340 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 504 | 0.340 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2009 | 4 | 0.330 |
Why?
|
| Hemostasis | 3 | 2022 | 68 | 0.310 |
Why?
|
| Hemostatics | 2 | 2022 | 58 | 0.310 |
Why?
|
| beta-Thalassemia | 1 | 2007 | 28 | 0.280 |
Why?
|
| Platelet Count | 4 | 2020 | 136 | 0.280 |
Why?
|
| Humans | 33 | 2024 | 124399 | 0.270 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3064 | 0.270 |
Why?
|
| Blood Coagulation Tests | 2 | 2022 | 60 | 0.240 |
Why?
|
| Pediatrics | 1 | 2014 | 1158 | 0.240 |
Why?
|
| Thrombin | 2 | 2022 | 59 | 0.240 |
Why?
|
| Administration, Oral | 2 | 2019 | 676 | 0.230 |
Why?
|
| Male | 16 | 2021 | 60951 | 0.230 |
Why?
|
| Thrombelastography | 2 | 2021 | 55 | 0.220 |
Why?
|
| Hospital Mortality | 4 | 2023 | 1019 | 0.210 |
Why?
|
| Thromboembolism | 1 | 2022 | 87 | 0.190 |
Why?
|
| Female | 14 | 2021 | 66372 | 0.180 |
Why?
|
| Consensus | 4 | 2024 | 628 | 0.180 |
Why?
|
| Disease Progression | 2 | 2019 | 2038 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 1266 | 0.170 |
Why?
|
| Adolescent | 9 | 2022 | 19327 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2007 | 823 | 0.170 |
Why?
|
| Patient Acuity | 1 | 2019 | 64 | 0.170 |
Why?
|
| Calcium Chloride | 1 | 2019 | 22 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 335 | 0.160 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2019 | 18 | 0.160 |
Why?
|
| Arginine Vasopressin | 1 | 2019 | 28 | 0.160 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2019 | 79 | 0.160 |
Why?
|
| Blood Coagulation | 2 | 2023 | 120 | 0.160 |
Why?
|
| Tennessee | 1 | 2018 | 27 | 0.160 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2018 | 3 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 135 | 0.150 |
Why?
|
| Acute Disease | 2 | 2020 | 1099 | 0.150 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 171 | 0.150 |
Why?
|
| Pandemics | 2 | 2024 | 1101 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 308 | 0.150 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2017 | 24 | 0.140 |
Why?
|
| Aging, Premature | 1 | 2017 | 30 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 200 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 1886 | 0.140 |
Why?
|
| Logistic Models | 2 | 2020 | 1802 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1016 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 260 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2017 | 176 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12285 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2024 | 16233 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 1183 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 972 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1687 | 0.120 |
Why?
|
| Baseball | 1 | 2014 | 6 | 0.120 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 34 | 0.110 |
Why?
|
| Thoracic Injuries | 1 | 2014 | 91 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2022 | 6099 | 0.110 |
Why?
|
| Gestational Age | 1 | 2017 | 1162 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 356 | 0.110 |
Why?
|
| Hydronephrosis | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2013 | 99 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 212 | 0.100 |
Why?
|
| Ascariasis | 1 | 2013 | 66 | 0.100 |
Why?
|
| Peritoneal Cavity | 1 | 2011 | 18 | 0.100 |
Why?
|
| Ureteral Obstruction | 1 | 2013 | 105 | 0.100 |
Why?
|
| Prognosis | 2 | 2019 | 4551 | 0.090 |
Why?
|
| Anthropometry | 1 | 2011 | 198 | 0.090 |
Why?
|
| Heparin | 2 | 2023 | 228 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2011 | 126 | 0.090 |
Why?
|
| Acalculous Cholecystitis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Drainage | 1 | 2011 | 257 | 0.090 |
Why?
|
| Cholecystitis, Acute | 1 | 2010 | 16 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5107 | 0.080 |
Why?
|
| Fever | 2 | 2010 | 296 | 0.080 |
Why?
|
| Treatment Refusal | 1 | 2009 | 77 | 0.080 |
Why?
|
| Encephalitis, Viral | 1 | 2008 | 22 | 0.080 |
Why?
|
| Steroids | 1 | 2009 | 203 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2013 | 948 | 0.070 |
Why?
|
| Enterovirus Infections | 1 | 2008 | 48 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1608 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2010 | 291 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 1 | 2010 | 671 | 0.070 |
Why?
|
| Heart Failure | 1 | 2019 | 2155 | 0.060 |
Why?
|
| Recurrence | 1 | 2009 | 1426 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2008 | 301 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 646 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2086 | 0.060 |
Why?
|
| Plasma Exchange | 1 | 2024 | 84 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 2811 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2022 | 38 | 0.050 |
Why?
|
| Fibrin | 1 | 2022 | 66 | 0.050 |
Why?
|
| Prevalence | 1 | 2007 | 2428 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 42 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2007 | 3264 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 96 | 0.040 |
Why?
|
| Transfusion Reaction | 1 | 2019 | 37 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2019 | 170 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 519 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2018 | 79 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2018 | 120 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 2415 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 969 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1247 | 0.030 |
Why?
|
| Heart Rate | 1 | 2019 | 588 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 816 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2018 | 324 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1156 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 870 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 1323 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3415 | 0.030 |
Why?
|
| Jaundice | 1 | 2010 | 27 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3724 | 0.020 |
Why?
|
| India | 1 | 2008 | 219 | 0.020 |
Why?
|
| United States | 1 | 2023 | 10757 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2010 | 306 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 1122 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10130 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 7249 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 29422 | 0.010 |
Why?
|